{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:41:59Z","timestamp":1771231319996,"version":"3.50.1"},"reference-count":30,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1136\/bjophthalmol-2016-308846","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T03:53:11Z","timestamp":1467258791000},"page":"525-529","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Association between self-reported bupropion use and glaucoma: a population-based study"],"prefix":"10.1136","volume":"101","author":[{"given":"Mariss\u00e9","family":"Mas\u00eds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Kakigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuldev","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,6,28]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2016-308846-1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-308846-2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ophtha.2013.09.003","article-title":"Long-term trends in glaucoma-related blindness in Olmsted County, Minnesota","volume":"121","author":"Malihi","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-308846-3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0197-2456(94)90046-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients","volume":"15","author":"Ederer","year":"1994","journal-title":"Control Clin Trials"},{"key":"key-10.1136\/bjophthalmol-2016-308846-4","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archopht.118.12.1639","volume":"118","author":"The advanced glaucoma intervention study, 6: Effect of cataract on visual field and visual acuity. The AGIS Investigators","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308846-5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308846-6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0002-9394(99)00369-4","article-title":"Collaborative normal-tension glaucoma study","volume":"128","author":"Sommer","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308846-7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0079-6123(08)01128-X","article-title":"TNF-alpha signaling in glaucomatous neurodegeneration","volume":"173","author":"Tezel","year":"2008","journal-title":"Prog Brain Res"},{"key":"key-10.1136\/bjophthalmol-2016-308846-8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1098-1136(200010)32:1<42::AID-GLIA40>3.0.CO;2-3","article-title":"Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head","volume":"32","author":"Yuan","year":"2000","journal-title":"Glia"},{"key":"key-10.1136\/bjophthalmol-2016-308846-9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainres.2003.10.029","article-title":"Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice","volume":"996","author":"Tezel","year":"2004","journal-title":"Brain Res"},{"key":"key-10.1136\/bjophthalmol-2016-308846-10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/bbrc.1997.7581","article-title":"Control of nitric oxide production by endogenous TNF-\u03b1 in mouse retinal pigmented epithelial and Muller glial cells","volume":"240","author":"Goureau","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"key-10.1136\/bjophthalmol-2016-308846-11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajo.2011.07.009","article-title":"A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-pressure Glaucoma Treatment Study","volume":"152","author":"Garudadri","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308846-12","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308846-13","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.transproceed.2013.04.010","article-title":"Bupropion reduces the inflammatory response and intestinal injury due to ischemia-reperfusion","volume":"45","author":"C\u00e1mara-Lemarroy","year":"2013","journal-title":"Transplant Proc"},{"key":"key-10.1136\/bjophthalmol-2016-308846-14","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1053\/gast.2001.29467","article-title":"Remission of Crohn's disease on bupropion","volume":"121","author":"Kast","year":"2001","journal-title":"Gastroenterology"},{"key":"key-10.1136\/bjophthalmol-2016-308846-15","first-page":"835","article-title":"Treatment of atopic dermatitis and psoriasis vulgaris with bupropion-SR: a pilot study","volume":"64","author":"Modell","year":"2002","journal-title":"Psychosom Med"},{"key":"key-10.1136\/bjophthalmol-2016-308846-16","doi-asserted-by":"crossref","first-page":"e0123682","DOI":"10.1371\/journal.pone.0123682","article-title":"Bupropion use and risk of open-angle glaucoma among enrollees in a Large U.S. managed care network","volume":"10","author":"Stein","year":"2015","journal-title":"PLoS ONE"},{"key":"key-10.1136\/bjophthalmol-2016-308846-17","unstructured":"National Health and Nutrition Examination Survey. NHANES 2005-2008. http:\/\/wwwn.cdc.gov\/nchs\/nhanes\/search\/nhanes07_08.aspx (accessed 15 Jun 2015)."},{"key":"key-10.1136\/bjophthalmol-2016-308846-18","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1001\/jamaophthalmol.2013.4694","article-title":"Socioeconomic disparity in use of eye care services among US adults with age-related eye diseases. National Health Interview Survey, 2002 and 2008","volume":"131","author":"Zhang","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308846-19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3129\/i10-120","article-title":"Eye care utilization in Canada: disparity in the publicly funded health care system","volume":"46","author":"Jin","year":"2011","journal-title":"Can J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308846-20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4103\/0301-4738.100529","article-title":"Social inequalities in blindness and visual impairment: a review of social determinants","volume":"60","author":"Ulldemolins","year":"2012","journal-title":"Indian J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308846-21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcjo.2012.10.003","article-title":"Socioeconomic status as a risk factor for late presentation of glaucoma in Canada","volume":"48","author":"Buys","year":"2013","journal-title":"Can J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308846-22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/jamaophthalmol.2013.577","article-title":"Accuracy of international classification of diseases, ninth revision, clinical modification billing codes for common ophthalmic conditions","volume":"131","author":"Muir","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308846-23","doi-asserted-by":"crossref","first-page":"e40065","DOI":"10.1371\/journal.pone.0040065","article-title":"Etanercept, a widely used inhibitor of tumor necrosis factor-\u03b1 (TNF-\u03b1), prevents retinal ganglion cell loss in a rat model of glaucoma","volume":"7","author":"Roh","year":"2012","journal-title":"PLoS ONE"},{"key":"key-10.1136\/bjophthalmol-2016-308846-24","first-page":"526","article-title":"Roles of tumor necrosis factor gene polymorphisms, tumor necrosis factor alpha level in aqueous humor, and the risk of open-angle glaucoma","volume":"19","author":"Xin","year":"2013","journal-title":"Mol Vis"},{"key":"key-10.1136\/bjophthalmol-2016-308846-25","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0025-6196(11)63149-2","article-title":"Bupropion sustained release for treatment of tobacco dependence","volume":"78","author":"Hays","year":"2003","journal-title":"Mayo Clinic Proceedings"},{"key":"key-10.1136\/bjophthalmol-2016-308846-26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s002130050022","article-title":"The effect of bupropion on nicotine craving and withdrawal","volume":"148","author":"Shiffman","year":"2000","journal-title":"Psychopharmacology"},{"key":"key-10.1136\/bjophthalmol-2016-308846-27","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jamaophthalmol.2015.2180","article-title":"Risk of angle-closure glaucoma with bupropion and topiramate","volume":"133","author":"Symes","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308846-28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/archopht.130.1.120","article-title":"Bilateral uveal effusion and angle-closure glaucoma associated with bupropion use","volume":"130","author":"Takusagawa","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-308846-29","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ophtha.2012.02.029","article-title":"Validity of self-reported eye disease and treatment in a population-based study: the Los Angeles Latino Eye Study","volume":"119","author":"Lauren","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-308846-30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11019-015-9662-5","article-title":"Time, space and form: necessary for causation in health, disease and intervention?","volume":"19","author":"Evans","year":"2016","journal-title":"Med Health Care Philos"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2016-308846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:53:11Z","timestamp":1601110391000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2016-308846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,28]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,3,21]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1136\/bjophthalmol-2016-308846"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2016-308846","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,28]]}}}